ReviewPharmacoEconomics2003

Eptifibatide: a pharmacoeconomic review of its use in percutaneous coronary intervention and acute coronary syndromes.

Greg L Plosker et al.PubMed ↗Publisher ↗

No numbers read from the abstract.